RxDoctor Payments Data

Vinod Rustgi, MD

Gastroenterology · New Brunswick, NJNPI 1679589121

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $335,220 of the $431,374 with a category attached, or 77.7%. 21 manufacturers reported payments, led by Madrigal Pharmaceuticals at 32.4% of the total. Among gastroenterology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$431,374in general payments, 2019–2025

Across 403 payments — averaging $1070.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Madrigal Pharmaceuticals$140K
  • Gilead$123K
  • AbbVie$111K
  • Intercept Pharmaceuticals, Inc.$9K
  • Mallinckrodt Enterprises LLC$7K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$6K
  • plus $36K from 15 others
$291,929in research payments, 2019–2025

Across 32 payments — averaging $9122.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$226K
  • AbbVie$48K
  • Dova Pharmaceuticals$9K
  • Boehringer Ingelheim$8K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$453
  • Boehringer Ingelheim International GmbH$62

What the payments were for

  • Consulting fees$62,51814%
  • Speaking & faculty fees$335,22078%
  • Travel & lodging$22,7765%
  • Food & beverage$10,8613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$431,374 in reported general payments places this provider in the 95th percentile of 701 gastroenterology providers in New Jersey.

See all gastroenterology providers in New Jersey

Medicare billing

Part B allowed, 2024
$26,734
Medicare patients
108
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ursodiol35$7,531
Tacrolimus17$5,551
Azathioprine13$796
Lactulose17$252
Omeprazole20$232
Spironolactone13$203
Pantoprazole Sodium15$106
Amlodipine Besylate13$19

Paid to pharmacies, not to this prescriber.

Other gastroenterology in New Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →